Publication: Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis
Issued Date
2010-08-01
Resource Type
Other identifier(s)
2-s2.0-78149241108
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS Neglected Tropical Diseases. Vol.4, No.8 (2010)
Suggested Citation
Maria G. Guzman, Thomas Jaenisch, Roger Gaczkowski, Vo Thi Ty Hang, Shamala Devi Sekaran, Axel Kroeger, Susana Vazquez, Didye Ruiz, Eric Martinez, Juan C. Mercado, Angel Balmaseda, Eva Harris, Efren Dimano, Prisca Susan A. Leano, Sutee Yoksan, Elci Villegas, Herminia Benduzu, Iris Villalobos, Jeremy Farrar, Cameron P. Simmons Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Neglected Tropical Diseases. Vol.4, No.8 (2010). doi:10.1371/journal.pntd.0000811 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/29587
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis
Author(s)
Maria G. Guzman
Thomas Jaenisch
Roger Gaczkowski
Vo Thi Ty Hang
Shamala Devi Sekaran
Axel Kroeger
Susana Vazquez
Didye Ruiz
Eric Martinez
Juan C. Mercado
Angel Balmaseda
Eva Harris
Efren Dimano
Prisca Susan A. Leano
Sutee Yoksan
Elci Villegas
Herminia Benduzu
Iris Villalobos
Jeremy Farrar
Cameron P. Simmons
Thomas Jaenisch
Roger Gaczkowski
Vo Thi Ty Hang
Shamala Devi Sekaran
Axel Kroeger
Susana Vazquez
Didye Ruiz
Eric Martinez
Juan C. Mercado
Angel Balmaseda
Eva Harris
Efren Dimano
Prisca Susan A. Leano
Sutee Yoksan
Elci Villegas
Herminia Benduzu
Iris Villalobos
Jeremy Farrar
Cameron P. Simmons
Other Contributor(s)
Abstract
Background:Early diagnosis of dengue can assist patient triage and management and prevent unnecessary treatments and interventions. Commercially available assays that detect the dengue virus protein NS1 in the plasma/serum of patients offers the possibility of early and rapid diagnosis. Methodology/Principal Findings:The sensitivity and specificity of the Pan-E Dengue Early ELISA and the PlateliaTMDengue NS1 Ag assays were compared against a reference diagnosis in 1385 patients in 6 countries in Asia and the Americas. Platelia was more sensitive (66%) than Pan-E (52%) in confirmed dengue cases. Sensitivity varied by geographic region, with both assays generally being more sensitive in patients from SE Asia than the Americas. Both kits were more sensitive for specimens collected within the first few days of illness onset relative to later time points. Pan-E and Platelia were both 100% specific in febrile patients without evidence of acute dengue. In patients with other confirmed diagnoses and healthy blood donors, Platelia was more specific (100%) than Pan-E (90%). For Platelia, when either the NS1 test or the IgM test on the acute sample was positive, the sensitivity versus the reference result was 82% in samples collected in the first four days of fever. NS1 sensitivity was not associated to disease severity (DF or DHF) in the Platelia test, whereas a trend for higher sensitivity in DHF cases was seen in the Pan-E test (however combined with lower overall sensitivity). Conclusions/Significance:Collectively, this multi-country study suggests that the best performing NS1 assay (Platelia) had moderate sensitivity (median 64%, range 34-76%) and high specificity (100%) for the diagnosis of dengue. The poor sensitivity of the evaluated assays in some geographical regions suggests further assessments are needed. The combination of NS1 and IgM detection in samples collected in the first few days of fever increased the overall dengue diagnostic sensitivity. © 2010 Guzman et al.